Advances in the treatment of large granular lymphocytic leukemia
LGLL management is undergoing a paradigm shift with the emergence of multiple targeted therapeutic approaches. Future progress will depend on better prognostic stratification, better integration of disease and patient heterogeneity, and the development of personalized treatment strategies, potentially supported by molecular monitoring.
Authors
- Mathilde Guégan
- Thierry Lamy
Institutions
- Inserm (FR)
- Université Rennes 2 (FR)
- Établissement Français du Sang (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
Publication Details
- Journal
- Expert Review of Hematology
- Published
- 2026-01-09
- DOI
- https://doi.org/10.1080/17474086.2026.2613733
- Primary Topic
- Chronic Lymphocytic Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00